Priority Date: 09.09.11 (CN 20111280441)

VASCULAR ENDOTHELIAL MYOSTATIN MUTANT THAT MUTATES AT ATP BINDING SITES

  • Application ID: EP12830317
  • Status: The patent has been granted

Applicant

Research organisation logo small
Research Organisation

Attorney

Employment test 51 - 200 employees
Company dna hoffmann eitle
operating since 1892
Headquarter in Munich and 6 offices
active in Legal Services and IP Portfolio Processing

Specialization

This EP application has the IPC combination A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 126 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 09.09.2011 - Priority Date (CN 20111280441)
  • 14.03.2013 - Publication A1 (WO2013034116)
  • 16.07.2014 - Publication A1 (EP2754718)
  • 13.12.2017 - Publication B1 (EP2754718)